Venrock Adviser, LLC
CIK 1615982
13F filing for Q2 2026・No. 1,211
- Holdings
- US$3.3B
- Quarter change
- +US$618.93M
- Entries
- 33
- Net bought (estimate)
- −US$271.18M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 4
- Sold out 4
- Cut 5
- Added 5
- Corporate actions 0
- Unchanged 19
Largest holdings
33 stocks worth US$3.3B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| APGEAPOGEE THERAPEUTICS INCCOM | Unchanged | 8,493,321 | US$1.13B | 34.18% |
| ORUKA THERAPEUTICS INCCOM | Unchanged | 4,148,428 | US$394.81M | 11.97% |
| ERASCA INCCOM | Added | 17,891,812 | US$327.78M | 9.94% |
| SYRESPYRE THERAPEUTICS INCCOM NEW | Cut | 2,985,448 | US$265.05M | 8.04% |
| DIANTHUS THERAPEUTICS INCCOM | Unchanged | 1,180,000 | US$115.03M | 3.49% |
| OCULAR THERAPEUTIX INCCOM | Unchanged | 10,346,926 | US$101.61M | 3.08% |
| DAMORA THERAPEUTICS INCCOM NEW | Unchanged | 3,603,595 | US$93.73M | 2.84% |
| SAVARA INCCOM | Added | 14,745,943 | US$90.84M | 2.75% |
| JADE BIOSCIENCES INCCOM NEW | Unchanged | 3,220,364 | US$71.56M | 2.17% |
| COGTCOGENT BIOSCIENCES INCCOM | Cut | 1,642,166 | US$63.55M | 1.93% |
Sign in (free) to see its 33 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.